サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1362904

在宅化学療法サービスの市場規模、シェア、動向分析レポート：製品別、がんタイプ別、地域別、セグメント別予測、2023年～2030年

Chemotherapy At Home Services Market Size, Share & Trends Analysis Report By Product (Oral, Infusion), By Cancer Type (Leukemia, Lung Cancer, Breast Cancer, Colon Cancer, Rectum Cancer), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 168 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
在宅化学療法サービスの市場規模、シェア、動向分析レポート：製品別、がんタイプ別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月06日
発行: Grand View Research
ページ情報: 英文 168 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

在宅化学療法サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の在宅化学療法サービス市場規模は2030年までに26億3,000万米ドルに達する見込みです。

予測期間中のCAGRは8.28%と予測されています。同市場の成長の背景には、病院から在宅ケアへの患者シフトの増加があります。さらに、病院での治療に比べてサービスのコストが低いことも、同市場の需要を押し上げると予想されます。

がん患者は、患者の安全性と利便性を確保しながら遠隔地での治療の恩恵を受けるために、技術的に進歩または改良された化学療法装置や遠隔医療を急速に採用しています。これが予測期間中の市場成長を押し上げると予想されます。化学療法薬の投与を改善するために、最近多くの携帯型機器が発売され、市場の成長に貢献しています。例えば、2022年3月、Shanghai MicroPort Lifesciences Co.Ltd.は、中国国家医療製品管理局（NMPA）から「AutoEx Chemotherapy Infusion Pump」の販売承認を取得しました。

COVID-19の大流行は、需要の増加と医師による在宅化学療法サービスの推進により、市場にプラスの影響を与えました。さらに、病院ではベッド数が不足しているため、各社は患者を病院から在宅に移行させることに注力し、サービスに対する需要を喚起しました。そのため、多くのサービスプロバイダーが、パンデミック後の化学療法需要の増加に対応するためのサービスを開始しました。例えば、2022年9月、JivikaヘルスケアはムンバイでChemoAtHomeサービスを開始し、患者に手頃な価格で質の高いがん治療サービスへのアクセスを提供しました。

在宅化学療法サービス市場レポートのハイライト

  • 製品別では、経口剤が2022年に最大の市場シェアを占めたが、これは製品のコストが低いことと、そのような製品に対する償還が市場で利用可能であることによる。
  • がんの種類別では、化学療法が白血病患者の主な治療法の1つと考えられていることから、白血病が2022年の市場を独占しました。このセグメントのシェアが高いのは、白血病患者が在宅化学療法を好む傾向が高いためと考えられます。
  • 地域別では、北米地域が2022年に最大の市場シェアを占めたが、これは同地域におけるがん罹患率の増加、および在宅化学療法サービスを提供するプロバイダー数の増加によるものです。
  • 市場は非常に断片化されており、在宅化学療法サービスを提供する小規模事業者が存在しています。発展途上国の多くの企業は、がん治療センターと提携して在宅がん治療サービスを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTLE分析
  • COVID-19感染症の影響分析

第4章 在宅化学療法サービス市場：製品の推定・動向分析

  • セグメントの定義
  • 在宅化学療法サービス市場：製品のセグメントダッシュボード
  • 在宅化学療法サービス市場：製品の動向と市場シェア分析
  • 経口
  • 点滴

第5章 在宅化学療法サービス市場：がんタイプの推定・動向分析

  • セグメントの定義
  • 在宅化学療法サービス市場：がんタイプのセグメントダッシュボード
  • 在宅化学療法サービス市場：がんタイプの動向と市場シェア分析
  • 白血病
  • 肺がん
  • 乳がん
  • 結腸がん
  • 直腸がん
  • 子宮頸がん
  • 前立腺がん
  • 卵巣がん

第6章 在宅化学療法サービス市場：地域の推定・動向分析

  • 在宅化学療法サービス市場：地域の変動分析、2022年および2030年
  • 北米
    • 北米の在宅化学療法サービス市場推計・予測、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の在宅化学療法サービス市場推計・予測、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域の在宅化学療法サービス市場推計・予測、2018年から2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの在宅化学療法サービス市場推計・予測、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 中東およびアフリカの在宅化学療法サービス市場推計・予測、2018年から2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業プロファイル
    • Sciensus Pharma Services Limited
    • Portea Medical
    • Ubiqare
    • Penn Medicine（The Trustees of the University of Pennsylvania）
    • Advocate Health Care
    • View Health Pty Ltd group（chemo@home Pty Ltd）
    • Vitalis Health and Home Care Pty Ltd
    • Medibank Private Limited
    • TCP Homecare
    • LloydsPharmacy Clinical Homecare
  • 企業の分類
  • 企業の市況分析
  • 戦略マッピング

第8章 推奨事項/主要な市場洞察

図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 5 Global chemotherapy at home services market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 9 U.S. chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 11 Canada chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 13 Europe chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 16 UK chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 18 Germany chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 20 France chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 21 France chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 22 Italy chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 24 Spain chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 26 Denmark chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 28 Sweden chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 29 Sweden chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 30 Norway chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 31 Norway chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 35 Japan chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 36 Japan chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 India chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 38 India chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 39 China chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 40 China chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 41 Australia chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 43 Thailand chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 44 Thailand chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 45 South Korea chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 46 South Korea chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 47 Latin America chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 50 Brazil chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 51 Brazil chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 52 Mexico chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 53 Mexico chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 54 Argentina chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 59 South Africa chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 63 UAE chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance
  • Table 69 Key companies undergoing expansions
  • Table 70 Key companies undertaking acquisitions
  • Table 71 Key companies undergoing partnership & collaborations
  • Table 72 Key companies launching new products
  • Table 73 Key companies undergoing other strategies

List of Figures

  • Fig. 1 Chemotherapy At Home Services market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value - chain - based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market product & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Chemotherapy at home services market driver analysis
  • Fig. 13 Chemotherapy at home services market restraint analysis
  • Fig. 14 Chemotherapy at home services market: Porter's analysis
  • Fig. 15 Chemotherapy at home services market: PESTLE analysis
  • Fig. 16 Chemotherapy at home services market: Product outlook and key takeaways
  • Fig. 17 Chemotherapy at home services market: Product market share and movement analysis, 2022 - 2030
  • Fig. 18 Global oral market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Global infusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Chemotherapy at home services market: Cancer Type outlook and key takeaways
  • Fig. 21 Chemotherapy at home services market: Cancer Type market share analysis, 2022 - 2030
  • Fig. 22 Global leukemia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global lung cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Global breast cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Global colon cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global rectum cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Global cervix uteri cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global prostate cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Global ovarian cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 U.S.: Country dynamics
  • Fig. 34 Canada chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Canada: Country dynamics
  • Fig. 36 Europe chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 UK chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 UK: Country dynamics
  • Fig. 39 Germany chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany: Country dynamics
  • Fig. 41 France chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 France: Country dynamics
  • Fig. 43 Italy chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Italy: Country dynamics
  • Fig. 45 Spain chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Spain: Country dynamics
  • Fig. 47 Denmark chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark: Country dynamics
  • Fig. 49 Sweden chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden: Country dynamics
  • Fig. 51 Norway chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Norway: Country dynamics
  • Fig. 53 Asia - Pacific chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Japan chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Japan: Country dynamics
  • Fig. 56 China chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 China: Country dynamics
  • Fig. 58 India chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 India: Country dynamics
  • Fig. 60 Australia chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Australia: Country dynamics
  • Fig. 62 Thailand chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand: Country dynamics
  • Fig. 64 South Korea chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea: Country dynamics
  • Fig. 66 Latin America chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil: Country dynamics
  • Fig. 69 Mexico chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico: Country dynamics
  • Fig. 71 Argentina chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina: Country dynamics
  • Fig. 73 MEA chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa: Country dynamics
  • Fig. 76 Saudi Arabia chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia: Country dynamics
  • Fig. 78 UAE chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 UAE: Country dynamics
  • Fig. 80 Kuwait chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait: Country dynamics
  • Fig. 82 Key company categorization
  • Fig. 83 Company market position analysis
  • Fig. 84 Market participant categorization
  • Fig. 85 Strategy framework
目次
Product Code: GVR-4-68040-111-2

Chemotherapy At Home Services Market Growth & Trends:

The global chemotherapy at home services market size is expected to reach USD 2.63 billion by 2030, based on a new report by Grand View Research, Inc.. It is projected to register a CAGR of 8.28% during the forecast period. The market's growth can be attributed to the increasing shift of patients from hospital to home care settings. Moreover, the lower cost of services compared to hospital settings is expected to boost the demand for the market.

Cancer patients have rapidly adopted technologically advanced or improved chemotherapy devices and telemedicine to benefit from treatment at remote locations with patient safety and convenience. This is expected to boost the growth of the market over the forecast period. Many portable devices have been launched recently to improve the administration of chemotherapy drugs, contributing to the market's growth. For instance, in March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received marketing approval for "AutoEx Chemotherapy Infusion Pump" from the National Medical Products Administration (NMPA) of China.

The COVID-19 pandemic positively impacted the market owing to increased demand and physicians' promotion of chemotherapy at home services. Moreover, due to the shortage of beds in the hospital settings, companies were focusing on transitioning patients from the hospital to in-home, creating demand for the services. Hence, many service providers launched services to cater to the growing demand for chemotherapy post-pandemic. For instance, in September 2022, Jivika Healthcare launched the ChemoAtHome service in Mumbai to provide access to affordable and high-quality cancer care services to patients.

Chemotherapy At Home Services Report Highlights:

  • Based on the product, the oral segment held the largest market share in 2022 owing to the lower cost of the products and the availability of reimbursement for such products in the market
  • Based on the cancer type, leukemia dominated the market in 2022, as chemotherapy is considered one of the primary treatment methods for leukemia patients. The high share of the segment can be due to the high preference for home-based chemotherapy by leukemia patients
  • Based on the region, the North America region held the largest market share in 2022 owing to the growing incidence of cancer in the region, and the rising number of providers offering chemotherapy at home services
  • The market is highly fragmented, with the presence of small-scale businesses offering home-based chemotherapy services. Many companies in developing countries are partnering with cancer treatment centers to offer at home cancer treatment services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
    • 1.3.1. Information procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
    • 1.3.6. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. 1.5 Market Formulation & Validation
    • 1.5.1. Volume Price Analysis
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Research Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Increasing incidence of cancer
      • 3.1.1.2. Lower cost of home-based chemotherapy services compared to hospital based services
      • 3.1.1.3. Increasing technological advancements and government initiatives
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. Lower reimbursement for chemotherapy at home services
      • 3.1.2.2. Lack of skilled medical staff
  • 3.2. Industry Analysis Tools
    • 3.2.1. Porter's Five Forces Analysis
    • 3.2.2. PESTLE Analysis
  • 3.3. COVID-19 Impact Analysis

Chapter 4. Chemotherapy At Home Services Market: Product Estimates & Trend Analysis

  • 4.1. Segment Definitions
  • 4.2. Chemotherapy At Home Services Market: Product Segment Dashboard
  • 4.3. Chemotherapy At Home Services Market: Product Movement & Market Share Analysis
  • 4.4. Oral
    • 4.4.1. Oral Market, 2018 - 2030 (USD Million)
  • 4.5. Infusion
    • 4.5.1. Infusion Market, 2018 - 2030 (USD Million)

Chapter 5. Chemotherapy At Home Services Market: Cancer Type Estimates & Trend Analysis

  • 5.1. Segment Definitions
  • 5.2. Chemotherapy At Home Services Market: Cancer Type Segment Dashboard
  • 5.3. Chemotherapy At Home Services Market: Cancer Type Movement & Market share Analysis
  • 5.4. Leukemia
    • 5.4.1. Leukemia Market, 2018 - 2030 (USD Million)
  • 5.5. Lung Cancer
    • 5.5.1. Lung Cancer Market, 2018 - 2030 (USD Million)
  • 5.6. Breast Cancer
    • 5.6.1. Breast Cancer Market, 2018 - 2030 (USD Million)
  • 5.7. Colon Cancer
    • 5.7.1. Colon Cancer Market, 2018 - 2030 (USD Million)
  • 5.8. Rectum Cancer
    • 5.8.1. Rectum Cancer Market, 2018 - 2030 (USD Million)
  • 5.9. Cervix Uteri Cancer
    • 5.9.1. Cervix Uteri Cancer Market, 2018 - 2030 (USD Million)
  • 5.10. Prostate Cancer
    • 5.10.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
  • 5.11. Ovarian Cancer
    • 5.11.1. Ovarian Cancer Market, 2018 - 2030 (USD Million)

Chapter 6. Chemotherapy At Home Services Market: Regional Estimates & Trend Analysis

  • 6.1. Chemotherapy At Home Services Market: Regional Movement Analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Regulatory Scenario
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Regulatory Scenario
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Regulatory Scenario
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. U.K. Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Regulatory Scenario
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Regulatory Scenario
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Regulatory Scenario
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Regulatory Scenario
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Regulatory Scenario
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Regulatory Scenario
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Regulatory Scenario
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Scenario
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Japan Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Scenario
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. China Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Scenario
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Regulatory Scenario
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Regulatory Scenario
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Regulatory Scenario
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Scenario
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Scenario
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Mexico Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Scenario
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Argentina Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Scenario
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. South Africa Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Scenario
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Saudi Arabia Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Scenario
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Scenario
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Profiles
    • 7.1.1. Sciensus Pharma Services Limited
      • 7.1.1.1. Overview
      • 7.1.1.2. Financial Performance
      • 7.1.1.3. Service Benchmarking
      • 7.1.1.4. Strategic Initiatives
    • 7.1.2. Portea Medical
      • 7.1.2.1. Overview
      • 7.1.2.2. Financial Performance
      • 7.1.2.3. Service Benchmarking
      • 7.1.2.4. Strategic Initiatives
    • 7.1.3. Ubiqare
      • 7.1.3.1. Overview
      • 7.1.3.2. Financial Performance
      • 7.1.3.3. Service Benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. Penn Medicine (The Trustees of the University of Pennsylvania)
      • 7.1.4.1. Overview
      • 7.1.4.2. Financial Performance
      • 7.1.4.3. Service Benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. Advocate Health Care
      • 7.1.5.1. Overview
      • 7.1.5.2. Financial Performance
      • 7.1.5.3. Service Benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. View Health Pty Ltd group (chemo@home Pty Ltd)
      • 7.1.6.1. Overview
      • 7.1.6.2. Financial Performance
      • 7.1.6.3. Service Benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. Vitalis Health and Home Care Pty Ltd
      • 7.1.7.1. Overview
      • 7.1.7.2. Financial Performance
      • 7.1.7.3. Service Benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. Medibank Private Limited
      • 7.1.8.1. Overview
      • 7.1.8.2. Financial Performance
      • 7.1.8.3. Service Benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. TCP Homecare
      • 7.1.9.1. Overview
      • 7.1.9.2. Financial Performance
      • 7.1.9.3. Service Benchmarking
      • 7.1.9.4. Strategic Initiatives
    • 7.1.10. LloydsPharmacy Clinical Homecare
      • 7.1.10.1. Overview
      • 7.1.10.2. Financial Performance
      • 7.1.10.3. Service Benchmarking
      • 7.1.10.4. Strategic Initiatives
  • 7.2. Company Categorization
  • 7.3. Company Market Position Analysis
  • 7.4. Strategy Mapping

Chapter 8. Recommendations/Key Market Insights